Event Program

Thank you to our speakers, sponsors, and delegates who joined us in Raleigh for the summit! If you are interested in the 2026 event, please get in touch at info@hansonwade.com

Your Next Event In The Gene Therapy Series is:

View the Full Program for the 6th Gene Therapy for Ophthalmic Disorders Summit

This summit is your unique forum to learn and network with the brightest minds revolutionizing the industry. View your copy of the latest agenda to view the full speaker faculty, details about each session, and registration options.

Most Recent Brochure Cover

Having trouble downloading the brochure?
Let us know here and we’ll email it to you instead

Speaker Spotlight: Cherie Fathy

Cherie Fathy, Alnylam Pharmaceuticals

Former FDA Clinical Reviewer, Now Director of Clinical Research at Alnylam Pharmaceuticals

With experience as a former FDA Clinical Reviewer and Medical Officer - having left the Agency as recently as June 2025 - Cherie Fathy brings both fresh regulatory perspective and industry insight to one of ophthalmic gene therapy’s toughest challenges: novel endpoint development. Don’t miss the chance to hear what truly resonates with regulators - check out her session in the program!

The Summit In Numbers:

18+

Senior specialists sharing end-to-end ophthalmic gene therapy expertise

3+

Hours of exclusive clinical data from Atsena, Tern, & Adverum Therapeutics

2+

Hours of preclinical research insights from Sparing Vision, Axovia, & Coave Therapeutics

6+

Hours of high-yield networking with industry leaders & vendors

50:50

Preclinical and clinical content split across 3 days

Register Interest
Partner With Us